InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility
NEW YORK and HERZLIYA, Israel, Dec. 20, 2024 /PRNewswire/ — InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company“), is pleased to announce that further to the Company’s prior reports regarding the war-related damages and the reconstruction…